Portal de Oportunidades de Pesquisa – POP – Propesq

Objetivo: Amgen is delighted to announce the launch of the Competitive Grant Program in Bone Research, which will provide an opportunity for investigators from around the world to compete for individual grants of up to 150,000 USD for novel research proposals that seek to improve quality of osteoporosis care and patient outcomes.f

Inscrições: até 28 de junho de 2019

Mais informações no site.

Objetivo: The Award targets young entrepreneurs or entrepreneurial individuals who challenge technological or social needs in the real world. The Takeda Foundation believes that the challenging activities of young individuals trying to address real technological and social needs will lead to the creation of goods and services that enhance the well-being of people throughout the world, which is the mission of the Foundation.

Inscrições: até 28 de junho de 2019

Mais informações no site.

Objetivo: The purpose of this award is to fund physicians during the transition from a fellowship program to a faculty appointment.

Inscrições: até 27 de junho de 2019

Mais informações no site.

Objetivo: The 2020 St Andrews Prize for the Environment is now open for entries. To enter the Prize the project must meet our strict entry criteria. Please review the below statements and use the check boxes to confirm the project you are submitting is eligible.

Inscrições: até 21 de junho de 2019

Mais informações no site.

Objetivo: The NORD Rare Disease Research Grant Program was established in 1989 to encourage meritorious scientific and clinical studies designed to improve the diagnosis or therapy of rare “orphan” diseases. Grants will be awarded to qualified researchers to initiate small scientific research studies or clinical trials, the results of which could be used to obtain funding from the NIH, FDA, or other funding agencies, or to attract a corporate sponsor. Procedures or proposed therapeutic trials may be new, based on recent biochemical or pharmacological evidence, or in preliminary stages of clinical investigation. Evaluation of proposals will include careful consideration of protocol design, objectiveness of parameters measured, and statistical evaluation proposed. Protocols that will focus on cause, early detection, diagnosis, or treatment (pharmacological, devices, surgery, or dietary) will be given priority.

Inscrições: até 18 de junho de 2019

Mais informações no site.

Objetivo: The NORD Rare Disease Research Grant Program was established in 1989 to encourage meritorious scientific and clinical studies designed to improve the diagnosis or therapy of rare “orphan” diseases. Grants will be awarded to qualified researchers to initiate small scientific research studies or clinical trials, the results of which could be used to obtain funding from the NIH, FDA, or other funding agencies, or to attract a corporate sponsor. Procedures or proposed therapeutic trials may be new, based on recent biochemical or pharmacological evidence, or in preliminary stages of clinical investigation. Evaluation of proposals will include careful consideration of protocol design, objectiveness of parameters measured, and statistical evaluation proposed. Protocols that will focus on cause, early detection, diagnosis, or treatment (pharmacological, devices, surgery, or dietary) will be given priority.

Inscrições: até 18 de junho de 2019

Mais informações no site.

Objetivo: The NORD Rare Disease Research Grant Program was established in 1989 to encourage meritorious scientific and clinical studies designed to improve the diagnosis or therapy of rare “orphan” diseases. Grants will be awarded to qualified researchers to initiate small scientific research studies or clinical trials, the results of which could be used to obtain funding from the NIH, FDA, or other funding agencies, or to attract a corporate sponsor. Procedures or proposed therapeutic trials may be new, based on recent biochemical or pharmacological evidence, or in preliminary stages of clinical investigation. Evaluation of proposals will include careful consideration of protocol design, objectiveness of parameters measured, and statistical evaluation proposed. Protocols that will focus on cause, early detection, diagnosis, or treatment (pharmacological, devices, surgery, or dietary) will be given priority.

Inscrições: até 18 de junho de 2019

Mais informações no site.

Objetivo: The NORD Rare Disease Research Grant Program was established in 1989 to encourage meritorious scientific and clinical studies designed to improve the diagnosis or therapy of rare “orphan” diseases. Grants will be awarded to qualified researchers to initiate small scientific research studies or clinical trials, the results of which could be used to obtain funding from the NIH, FDA, or other funding agencies, or to attract a corporate sponsor. Procedures or proposed therapeutic trials may be new, based on recent biochemical or pharmacological evidence, or in preliminary stages of clinical investigation. Evaluation of proposals will include careful consideration of protocol design, objectiveness of parameters measured, and statistical evaluation proposed. Protocols that will focus on cause, early detection, diagnosis, or treatment (pharmacological, devices, surgery, or dietary) will be given priority.

Inscrições: até 18 de junho de 2019

Mais informações no site.

Objetivo: The aim is to fund ambitious transnational RTD projects addressing materials research and innovation including materials for low carbon energy technologies and related production technologies. M-ERA.NET aims to strengthen the contribution of materials R&D to energy-related applications where applicable.

Inscrições: até 18 de junho de 2019

Mais informações no site.

Objetivo: The NORD Rare Disease Research Grant Program was established in 1989 to encourage meritorious scientific and clinical studies designed to improve the diagnosis or therapy of rare “orphan” diseases. Grants will be awarded to qualified researchers to initiate small scientific research studies or clinical trials, the results of which could be used to obtain funding from the NIH, FDA, or other funding agencies, or to attract a corporate sponsor. Procedures or proposed therapeutic trials may be new, based on recent biochemical or pharmacological evidence, or in preliminary stages of clinical investigation. Evaluation of proposals will include careful consideration of protocol design, objectiveness of parameters measured, and statistical evaluation proposed. Protocols that will focus on cause, early detection, diagnosis, or treatment (pharmacological, devices, surgery, or dietary) will be given priority.

Inscrições: até 18 de junho de 2019

Mais informações no site.